Suppr超能文献

PET/CT 偶然发现胰腺肿瘤患者的第二肿瘤。

PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.

机构信息

Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic, University of Padua, Padua, Italy.

Department of Nuclear Medicine, Castelfranco Veneto General Hospital, Castelfranco Veneto, Treviso, Italy.

出版信息

BMC Cancer. 2018 May 4;18(1):531. doi: 10.1186/s12885-018-4469-4.

Abstract

BACKGROUND

Positron Emission Tomography/computed tomography (PET/CT) is an imaging technique which has a role in the detection and staging malignancies (both in first diagnosis and follow-up). The finding of an unexpected region of FDG (Fluorodeoxyglucose) uptake can occur when performing whole-body FDG-PET, raising the possibility of a second primary tumor. The aim of this study was to evaluate our experience of second primary cancer incidentally discovered during PET/CT examination performed for pancreatic diseases, during the initial work-up or follow-up after surgical resection.

METHODS

In this study, a retrospective evaluation of a prospectively collected data base was performed. Three hundred ninety- nine patients with pancreatic pathology were evaluated by whole body PET/CT imaging from January 2004 to December 2014. Among them, 348 patients were scanned before surgical resection and 51 during the course of their follow-up (pancreatic cancer). Median follow-up time was 29 months (range 14-124).

RESULTS

Fifty-six patients (14%) had incidental uptake of FDG in their organs: 31 patients had focal uptake and 25 showed diffuse with or without focal uptake. All patients with focal uptake were investigated, and invasive malignancy was diagnosed in 22 patients: 14 colon, 4 lung, 1 larynx, 1 urothelial, 1 breast cancer, and 1 colon metastasis from pancreatic cancer. Twenty patients underwent resection, and 6 endoscopic removal of colonic polyps. Three patients were not operated for advanced disease, and two patients did not show any pathology (PET/CT false positive). Of the 10 patients investigated for diffuse uptake, no malignancy was found; none of these patients developed a second cancer during the follow-up.

CONCLUSIONS

As in other malignancies, unexpected FDG uptake can occur in patients having PET/CT investigation for pancreatic diseases. Focal uptake is likely to be a malignancy and deserves further investigations, although the stage and the poor prognosis of primary pancreatic cancer should be kept in mind. Some selected patients may benefit from the aggressive treatment of incidental lesions and show survival benefit.

摘要

背景

正电子发射断层扫描/计算机断层扫描(PET/CT)是一种成像技术,在恶性肿瘤的检测和分期中具有一定的作用(包括首次诊断和随访)。在进行全身 FDG-PET 检查时,可能会在意外区域发现 FDG(氟脱氧葡萄糖)摄取,从而提示可能存在第二原发性肿瘤。本研究的目的是评估我们在因胰腺疾病进行的 PET/CT 检查中发现的第二原发性肿瘤的经验,这些检查是在手术切除的初始检查或随访期间进行的。

方法

本研究回顾性评估了一项前瞻性收集的数据。2004 年 1 月至 2014 年 12 月,399 例胰腺疾病患者接受了全身 PET/CT 成像检查。其中,348 例患者在手术切除前进行了扫描,51 例在随访期间(胰腺癌)进行了扫描。中位随访时间为 29 个月(范围 14-124)。

结果

56 例患者(14%)的器官有意外 FDG 摄取:31 例有局灶性摄取,25 例有弥漫性摄取,伴或不伴局灶性摄取。所有局灶性摄取的患者均进行了进一步检查,22 例诊断为侵袭性恶性肿瘤:14 例结肠癌、4 例肺癌、1 例喉癌、1 例尿路上皮癌、1 例乳腺癌和 1 例胰腺癌结肠转移。20 例患者接受了手术切除,6 例患者接受了结肠息肉的内镜下切除。3 例患者因晚期疾病未接受手术,2 例患者未发现任何病理学改变(PET/CT 假阳性)。10 例弥漫性摄取患者未发现恶性肿瘤;在随访期间,这些患者均未发生第二原发性癌症。

结论

与其他恶性肿瘤一样,在因胰腺疾病进行 PET/CT 检查的患者中,可能会出现意外的 FDG 摄取。局灶性摄取很可能是恶性肿瘤,需要进一步检查,尽管应考虑到原发性胰腺癌的分期和预后不良。一些选择的患者可能受益于意外病变的积极治疗,并表现出生存获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d6/5936016/a68b26e04f1e/12885_2018_4469_Fig1_HTML.jpg

相似文献

1
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.
BMC Cancer. 2018 May 4;18(1):531. doi: 10.1186/s12885-018-4469-4.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Evaluation of Colonoscopic Results of Patients with Incidental Colonic FDG Uptake in PET/CT Imaging.
World J Surg. 2023 Oct;47(10):2532-2541. doi: 10.1007/s00268-023-07135-w. Epub 2023 Jul 30.
8
Incidental PET/CT findings in the cancer patient: how should they be managed?
Surgery. 2009 Aug;146(2):274-81. doi: 10.1016/j.surg.2009.04.024.

本文引用的文献

2
Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer.
BMC Pulm Med. 2015 Dec 2;15:152. doi: 10.1186/s12890-015-0152-6.
4
Ability of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancer.
Br J Radiol. 2014 Oct;87(1042):20140030. doi: 10.1259/bjr.20140030. Epub 2014 Aug 13.
5
Clinical significance of incidental findings on staging positron emission tomography for oesophagogastric malignancies.
Ann R Coll Surg Engl. 2014 Apr;96(3):207-10. doi: 10.1308/003588414X13814021678871.
6
Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations.
World J Gastroenterol. 2014 Apr 21;20(15):4377-81. doi: 10.3748/wjg.v20.i15.4377.
8
The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey.
Ann Nucl Med. 2013 Jan;27(1):46-57. doi: 10.1007/s12149-012-0660-x. Epub 2012 Oct 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验